Saman Rasoul

Impact of opioids on P2Y(12) receptor inhibition in patients with ST-elevationmyocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial

Tavenier, A. H., Hermanides, R. S., Ottervanger, J. P., Tolsma, R., van Beurden, A., Slingerland, R. J., Ter Horst, P. G. J., Gosselink, A. T. M., Dambrink, J. H. E., van Leeuwen, M. A. H., Roolvink, V., Kedhi, E., Klungel, O. H., Belitser, S. V., Angiolillo, D. J., Pustjens, T., Rasoul, S., Gho, B., Stein, M., Ruiters, L., & 1 othersHof, A. W. J. V., 1 Jan 2022, In: European Heart Journal-Cardiovascular Pharmacotherapy. 8, 1, p. 4-12 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome

Pustjens, T. F. S., Timmermans, M. J. C., Rasoul, S., van't Hof, A. W. J., Netherlands Heart Registration & PCI Registration Committee, 1 Oct 2022, In: Journal of Clinical Medicine. 11, 20, 13 p., 6144.

Research output: Contribution to journal › Article › Academic › peer-review

Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study

Pustjens, T. F. S., Vranken, N. P. A., Jansen, G., Winkler, P. J. C., Stein, M., Hoebers, L., Kietselaer, B., Spaanderman, M. E. A., Rasoul, S., Ghossein-Doha, C. & van 't Hof, A. W. J., 15 Jul 2022, In: Frontiers in cardiovascular medicine. 9, 10 p., 932799.

Research output: Contribution to journal › Article › Academic › peer-review

Unraveling the Multitude of Etiologies in Myocardial Infarction With Nonobstructive Coronary Arteries

Pustjens, T. F. S., Vranken, N. P. A., Hermanides, R. S., Rasoul, S., Ottervanger, J. P. & Van't Hof, A. W. J., 1 Apr 2022, In: American Journal of Cardiology. 168, p. 17-21 5 p.

Research output: Contribution to journal › Article › Academic › peer-review

Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry

Selvarajah, A., Tavenier, A. H., Bor, W. L., Houben, A. J. H. M., Rasoul, S., Kaplan, E., Teeuwen, K., Hofma, S. H., Lipsic, E., Amoroso, G., van Leeuwen, M. A. H., ten Berg, J. M., van 't Hof, A. W. J. & Hermanides, R. S., 12 Jun 2021, In: BMC Cardiovascular disorders. 21, 1, 7 p., 292.

Research output: Contribution to journal › Article › Academic › peer-review